462510 — Lameditech Co Income Statement
0.000.00%
Last trade - 00:00- KR₩72bn
- KR₩62bn
- KR₩7bn
Annual income statement for Lameditech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | KAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1,029 | 2,056 | 2,918 | 6,577 |
| Cost of Revenue | ||||
| Gross Profit | 367 | 285 | 899 | 2,357 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 2,910 | 5,400 | 6,444 | 16,239 |
| Operating Profit | -1,881 | -3,344 | -3,526 | -9,662 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1,867 | -4,430 | -8,305 | -9,484 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1,867 | -4,430 | -8,305 | -9,484 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -1,867 | -4,430 | -8,305 | -9,484 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1,867 | -4,430 | -8,305 | -9,484 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -216 | -512 | -960 | -1,177 |
| Dividends per Share |